Roger J. Pomerantz's Insider Trades & SAST Disclosures
Roger J. Pomerantz's most recent trade in Viracta Therapeutics Inc was a trade of 9,034 Restricted Stock Units done . Disclosure was reported to the exchange on Nov. 25, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Roger J. Pomerantz.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Viracta Therapeutics Inc | Pomerantz J. Roger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2024 | 9,034 | 18,069 | - | - | Restricted Stock Units | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2024 | 9,034 | 126,478 | - | 0 | Common Stock | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2024 | 9,034 | 27,103 | - | - | Restricted Stock Units | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2024 | 9,034 | 117,444 | - | 0 | Common Stock | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 18,750 | 18,750 | - | - | Stock Option (Right to Buy) | |
| Indaptus Therapeutics Inc | Roger J. Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2024 | 9,035 | 36,137 | - | - | Restricted Stock Units | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2024 | 9,035 | 108,410 | - | 0 | Common Stock | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2024 | 9,034 | 99,375 | - | 0 | Common Stock | |
| Viracta Therapeutics Inc | Pomerantz J. Roger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2024 | 9,034 | 45,172 | - | - | Restricted Stock Units | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 9,034 | 81,307 | - | 0 | Common Stock | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 9,034 | 63,240 | - | - | Restricted Stock Units | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Indaptus Therapeutics Inc | Roger J. Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2023 | 9,034 | 81,309 | - | - | Restricted Stock Units | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2023 | 9,034 | 63,238 | - | 0 | Common Stock | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2022 | 9,034 | 54,204 | - | 0 | Common Stock | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2022 | 9,034 | 90,343 | - | - | Restricted Stock Units | |
| Indaptus Therapeutics Inc | Roger J. Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 81,000 | 81,000 | - | - | Stock Option (right to buy) | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2022 | 9,034 | 45,170 | - | 0 | Common Stock | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2022 | 9,034 | 99,377 | - | - | Restricted Stock Units | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 30,282 | 30,282 | - | - | Stock Option (Right to Buy) | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2022 | 9,034 | 108,411 | - | - | Restricted Stock Units | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2022 | 9,034 | 36,136 | - | 0 | Common Stock | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 9,034 | 27,102 | - | 0 | Common Stock | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 9,034 | 117,445 | - | - | Restricted Stock Units | |
| ContraFect Corp | Roger J. Pomerantz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 500,000 | 500,000 | - | - | Options (Right to Buy) | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2021 | 18,068 | 126,479 | - | - | Restricted Stock Units | |
| Viracta Therapeutics Inc | Roger J. Pomerantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2021 | 18,068 | 18,068 | - | 0 | Common Stock | |
| Indaptus Therapeutics Inc | Roger J. Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 41,000 | 41,000 | - | - | Stock Option (right to buy) | |
| ContraFect Corp | Roger J. Pomerantz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2021 | 254,000 | 254,000 | - | - | Options (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges